0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Donepezil Drug Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-3W9550
Home | Market Reports | Health| Aging & Geriatrics
Global Donepezil Drug Market Research Report 2022
BUY CHAPTERS

Global Donepezil Drug Market Research Report 2024

Code: QYRE-Auto-3W9550
Report
February 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Donepezil Drug Market Size

The global Donepezil Drug market was valued at US$ 1241 million in 2023 and is anticipated to reach US$ 1822.5 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.

Donepezil Drug Market

Donepezil Drug Market Trends

The market for the medication donepezil is growing as a result of numerous important causes. First and foremost, a major factor is the rising incidence of neurological illnesses like Alzheimer's disease. The frequency of Alzheimer's and associated diseases is rising as the world's population ages, which is driving up demand for drugs like donepezil, which is frequently used to control symptoms and halt the course of the illness. Second, continued technological and scientific developments in the medical field support the market's growth. The effectiveness and attractiveness of medications like donepezil are increased by our growing knowledge of the fundamental mechanisms behind Alzheimer's disease and the creation of increasingly successful treatment plans. 

In addition, regulatory actions and healthcare regulations have a significant impact on the market environment for the medication donepezil. Tight laws controlling safety requirements and drug approval procedures guarantee the effectiveness and quality of drugs, giving patients and healthcare professionals trust. Growth in the market is also aided by government efforts and advantageous reimbursement rules that provide access to healthcare treatments for people with Alzheimer's disease. Additionally, the strategic marketing initiatives and R&D expenditures of pharmaceutical firms spur innovation and enable the launch of novel dosage forms and formulations, therefore broadening the market for donepezil and improving patient results.

Donepezil Drug Market Share

A geographical analysis of the donepezil medicine market reveals complex patterns that depend on a number of variables. The market for donepezil is strong in North America since the region has a high incidence of Alzheimer's disease and a developed healthcare system. The area experiences growth in the market due to advantageous reimbursement policies and substantial research and development efforts. In a similar vein, Europe is seeing a notable increase in demand for donepezil due to a growing senior population and more knowledge of the condition. On the other hand, the Asia-Pacific area offers distinct prospects for market growth, driven by elements including the swiftly aging population, growing healthcare spending, and growing consciousness about neurodegenerative illnesses. 

Scope of Donepezil Drug Market Report

Report Metric Details
Report Name Donepezil Drug Market
Accounted market size in 2023 US$ 1241 million
Forecasted market size in 2030 US$ 1822.5 million
CAGR 5.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • 5mg
  • 10mg
  • 23mg
Segment by Application
  • Hospitals
  • Clinics
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eisai, Pfizer, Teva, Novartis, Apotex, Dr Reddy's Laboratories, Sun Pharmaceutical, Hansoh Pharma, Cipla, ARK PHA.LTD, Jishengtang Pharma, Luoxin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Donepezil Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Donepezil Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Donepezil Drug Market growing?

Ans: The Donepezil Drug Market witnessing a CAGR of 5.5% during the forecast period 2024-2030.

What is the Donepezil Drug Market size in 2030?

Ans: The Donepezil Drug Market size in 2030 will be US$ 1822.5 million.

Who are the main players in the Donepezil Drug Market report?

Ans: The main players in the Donepezil Drug Market are Eisai, Pfizer, Teva, Novartis, Apotex, Dr Reddy's Laboratories, Sun Pharmaceutical, Hansoh Pharma, Cipla, ARK PHA.LTD, Jishengtang Pharma, Luoxin

What are the Application segmentation covered in the Donepezil Drug Market report?

Ans: The Applications covered in the Donepezil Drug Market report are Hospitals, Clinics, Drugstore

What are the Type segmentation covered in the Donepezil Drug Market report?

Ans: The Types covered in the Donepezil Drug Market report are 5mg, 10mg, 23mg

Recommended Reports

Neurodegenerative Diseases

Cognitive Health Drugs

Central Nervous System

1 Donepezil Drug Market Overview
1.1 Product Overview and Scope of Donepezil Drug
1.2 Donepezil Drug Segment by Type
1.2.1 Global Donepezil Drug Market Value Comparison by Type (2024-2030)
1.2.2 5mg
1.2.3 10mg
1.2.4 23mg
1.3 Donepezil Drug Segment by Application
1.3.1 Global Donepezil Drug Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Global Donepezil Drug Market Size Estimates and Forecasts
1.4.1 Global Donepezil Drug Revenue 2019-2030
1.4.2 Global Donepezil Drug Sales 2019-2030
1.4.3 Global Donepezil Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Donepezil Drug Market Competition by Manufacturers
2.1 Global Donepezil Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Donepezil Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Donepezil Drug Average Price by Manufacturers (2019-2024)
2.4 Global Donepezil Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Donepezil Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Donepezil Drug, Product Type & Application
2.7 Donepezil Drug Market Competitive Situation and Trends
2.7.1 Donepezil Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Donepezil Drug Players Market Share by Revenue
2.7.3 Global Donepezil Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Donepezil Drug Retrospective Market Scenario by Region
3.1 Global Donepezil Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Donepezil Drug Global Donepezil Drug Sales by Region: 2019-2030
3.2.1 Global Donepezil Drug Sales by Region: 2019-2024
3.2.2 Global Donepezil Drug Sales by Region: 2025-2030
3.3 Global Donepezil Drug Global Donepezil Drug Revenue by Region: 2019-2030
3.3.1 Global Donepezil Drug Revenue by Region: 2019-2024
3.3.2 Global Donepezil Drug Revenue by Region: 2025-2030
3.4 North America Donepezil Drug Market Facts & Figures by Country
3.4.1 North America Donepezil Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Donepezil Drug Sales by Country (2019-2030)
3.4.3 North America Donepezil Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Donepezil Drug Market Facts & Figures by Country
3.5.1 Europe Donepezil Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Donepezil Drug Sales by Country (2019-2030)
3.5.3 Europe Donepezil Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Donepezil Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Donepezil Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Donepezil Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Donepezil Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Donepezil Drug Market Facts & Figures by Country
3.7.1 Latin America Donepezil Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Donepezil Drug Sales by Country (2019-2030)
3.7.3 Latin America Donepezil Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Donepezil Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Donepezil Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Donepezil Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Donepezil Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Donepezil Drug Sales by Type (2019-2030)
4.1.1 Global Donepezil Drug Sales by Type (2019-2024)
4.1.2 Global Donepezil Drug Sales by Type (2025-2030)
4.1.3 Global Donepezil Drug Sales Market Share by Type (2019-2030)
4.2 Global Donepezil Drug Revenue by Type (2019-2030)
4.2.1 Global Donepezil Drug Revenue by Type (2019-2024)
4.2.2 Global Donepezil Drug Revenue by Type (2025-2030)
4.2.3 Global Donepezil Drug Revenue Market Share by Type (2019-2030)
4.3 Global Donepezil Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Donepezil Drug Sales by Application (2019-2030)
5.1.1 Global Donepezil Drug Sales by Application (2019-2024)
5.1.2 Global Donepezil Drug Sales by Application (2025-2030)
5.1.3 Global Donepezil Drug Sales Market Share by Application (2019-2030)
5.2 Global Donepezil Drug Revenue by Application (2019-2030)
5.2.1 Global Donepezil Drug Revenue by Application (2019-2024)
5.2.2 Global Donepezil Drug Revenue by Application (2025-2030)
5.2.3 Global Donepezil Drug Revenue Market Share by Application (2019-2030)
5.3 Global Donepezil Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eisai
6.1.1 Eisai Corporation Information
6.1.2 Eisai Description and Business Overview
6.1.3 Eisai Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eisai Donepezil Drug Product Portfolio
6.1.5 Eisai Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Donepezil Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Donepezil Drug Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Donepezil Drug Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Corporation Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apotex Donepezil Drug Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 Dr Reddy's Laboratories
6.6.1 Dr Reddy's Laboratories Corporation Information
6.6.2 Dr Reddy's Laboratories Description and Business Overview
6.6.3 Dr Reddy's Laboratories Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr Reddy's Laboratories Donepezil Drug Product Portfolio
6.6.5 Dr Reddy's Laboratories Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Donepezil Drug Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Hansoh Pharma
6.8.1 Hansoh Pharma Corporation Information
6.8.2 Hansoh Pharma Description and Business Overview
6.8.3 Hansoh Pharma Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hansoh Pharma Donepezil Drug Product Portfolio
6.8.5 Hansoh Pharma Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Donepezil Drug Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 ARK PHA.LTD
6.10.1 ARK PHA.LTD Corporation Information
6.10.2 ARK PHA.LTD Description and Business Overview
6.10.3 ARK PHA.LTD Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ARK PHA.LTD Donepezil Drug Product Portfolio
6.10.5 ARK PHA.LTD Recent Developments/Updates
6.11 Jishengtang Pharma
6.11.1 Jishengtang Pharma Corporation Information
6.11.2 Jishengtang Pharma Donepezil Drug Description and Business Overview
6.11.3 Jishengtang Pharma Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jishengtang Pharma Donepezil Drug Product Portfolio
6.11.5 Jishengtang Pharma Recent Developments/Updates
6.12 Luoxin
6.12.1 Luoxin Corporation Information
6.12.2 Luoxin Donepezil Drug Description and Business Overview
6.12.3 Luoxin Donepezil Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Luoxin Donepezil Drug Product Portfolio
6.12.5 Luoxin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Donepezil Drug Industry Chain Analysis
7.2 Donepezil Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Donepezil Drug Production Mode & Process
7.4 Donepezil Drug Sales and Marketing
7.4.1 Donepezil Drug Sales Channels
7.4.2 Donepezil Drug Distributors
7.5 Donepezil Drug Customers
8 Donepezil Drug Market Dynamics
8.1 Donepezil Drug Industry Trends
8.2 Donepezil Drug Market Drivers
8.3 Donepezil Drug Market Challenges
8.4 Donepezil Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Donepezil Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Donepezil Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Donepezil Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Donepezil Drug Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Donepezil Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Donepezil Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Donepezil Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Donepezil Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Donepezil Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Donepezil Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Donepezil Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Donepezil Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Donepezil Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Donepezil Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Donepezil Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Donepezil Drug Sales by Region (2019-2024) & (K Units)
    Table 18. Global Donepezil Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Donepezil Drug Sales by Region (2025-2030) & (K Units)
    Table 20. Global Donepezil Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Donepezil Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Donepezil Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Donepezil Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Donepezil Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Donepezil Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Donepezil Drug Sales by Country (2019-2024) & (K Units)
    Table 27. North America Donepezil Drug Sales by Country (2025-2030) & (K Units)
    Table 28. North America Donepezil Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Donepezil Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Donepezil Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Donepezil Drug Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Donepezil Drug Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Donepezil Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Donepezil Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Donepezil Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Donepezil Drug Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Donepezil Drug Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Donepezil Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Donepezil Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Donepezil Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Donepezil Drug Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Donepezil Drug Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Donepezil Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Donepezil Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Donepezil Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Donepezil Drug Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Donepezil Drug Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Donepezil Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Donepezil Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Donepezil Drug Sales (K Units) by Type (2019-2024)
    Table 51. Global Donepezil Drug Sales (K Units) by Type (2025-2030)
    Table 52. Global Donepezil Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Donepezil Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Donepezil Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Donepezil Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Donepezil Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Donepezil Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Donepezil Drug Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Donepezil Drug Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Donepezil Drug Sales (K Units) by Application (2019-2024)
    Table 61. Global Donepezil Drug Sales (K Units) by Application (2025-2030)
    Table 62. Global Donepezil Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Donepezil Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Donepezil Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Donepezil Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Donepezil Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Donepezil Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Donepezil Drug Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Donepezil Drug Price (US$/Unit) by Application (2025-2030)
    Table 70. Eisai Corporation Information
    Table 71. Eisai Description and Business Overview
    Table 72. Eisai Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Eisai Donepezil Drug Product
    Table 74. Eisai Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Pfizer Donepezil Drug Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Teva Corporation Information
    Table 81. Teva Description and Business Overview
    Table 82. Teva Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Teva Donepezil Drug Product
    Table 84. Teva Recent Developments/Updates
    Table 85. Novartis Corporation Information
    Table 86. Novartis Description and Business Overview
    Table 87. Novartis Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Novartis Donepezil Drug Product
    Table 89. Novartis Recent Developments/Updates
    Table 90. Apotex Corporation Information
    Table 91. Apotex Description and Business Overview
    Table 92. Apotex Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Apotex Donepezil Drug Product
    Table 94. Apotex Recent Developments/Updates
    Table 95. Dr Reddy's Laboratories Corporation Information
    Table 96. Dr Reddy's Laboratories Description and Business Overview
    Table 97. Dr Reddy's Laboratories Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Dr Reddy's Laboratories Donepezil Drug Product
    Table 99. Dr Reddy's Laboratories Recent Developments/Updates
    Table 100. Sun Pharmaceutical Corporation Information
    Table 101. Sun Pharmaceutical Description and Business Overview
    Table 102. Sun Pharmaceutical Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Sun Pharmaceutical Donepezil Drug Product
    Table 104. Sun Pharmaceutical Recent Developments/Updates
    Table 105. Hansoh Pharma Corporation Information
    Table 106. Hansoh Pharma Description and Business Overview
    Table 107. Hansoh Pharma Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Hansoh Pharma Donepezil Drug Product
    Table 109. Hansoh Pharma Recent Developments/Updates
    Table 110. Cipla Corporation Information
    Table 111. Cipla Description and Business Overview
    Table 112. Cipla Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Cipla Donepezil Drug Product
    Table 114. Cipla Recent Developments/Updates
    Table 115. ARK PHA.LTD Corporation Information
    Table 116. ARK PHA.LTD Description and Business Overview
    Table 117. ARK PHA.LTD Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. ARK PHA.LTD Donepezil Drug Product
    Table 119. ARK PHA.LTD Recent Developments/Updates
    Table 120. Jishengtang Pharma Corporation Information
    Table 121. Jishengtang Pharma Description and Business Overview
    Table 122. Jishengtang Pharma Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Jishengtang Pharma Donepezil Drug Product
    Table 124. Jishengtang Pharma Recent Developments/Updates
    Table 125. Luoxin Corporation Information
    Table 126. Luoxin Description and Business Overview
    Table 127. Luoxin Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Luoxin Donepezil Drug Product
    Table 129. Luoxin Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Donepezil Drug Distributors List
    Table 133. Donepezil Drug Customers List
    Table 134. Donepezil Drug Market Trends
    Table 135. Donepezil Drug Market Drivers
    Table 136. Donepezil Drug Market Challenges
    Table 137. Donepezil Drug Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Donepezil Drug
    Figure 2. Global Donepezil Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Donepezil Drug Market Share by Type in 2023 & 2030
    Figure 4. 5mg Product Picture
    Figure 5. 10mg Product Picture
    Figure 6. 23mg Product Picture
    Figure 7. Global Donepezil Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Donepezil Drug Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Drugstore
    Figure 12. Global Donepezil Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Donepezil Drug Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Donepezil Drug Sales (2019-2030) & (K Units)
    Figure 15. Global Donepezil Drug Average Price (US$/Unit) & (2019-2030)
    Figure 16. Donepezil Drug Report Years Considered
    Figure 17. Donepezil Drug Sales Share by Manufacturers in 2023
    Figure 18. Global Donepezil Drug Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Donepezil Drug Players: Market Share by Revenue in 2023
    Figure 20. Donepezil Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Donepezil Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Donepezil Drug Sales Market Share by Country (2019-2030)
    Figure 23. North America Donepezil Drug Revenue Market Share by Country (2019-2030)
    Figure 24. United States Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Donepezil Drug Sales Market Share by Country (2019-2030)
    Figure 27. Europe Donepezil Drug Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Donepezil Drug Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Donepezil Drug Revenue Market Share by Region (2019-2030)
    Figure 35. China Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Donepezil Drug Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Donepezil Drug Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Donepezil Drug Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Donepezil Drug Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Donepezil Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Donepezil Drug by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Donepezil Drug by Type (2019-2030)
    Figure 56. Global Donepezil Drug Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Donepezil Drug by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Donepezil Drug by Application (2019-2030)
    Figure 59. Global Donepezil Drug Price (US$/Unit) by Application (2019-2030)
    Figure 60. Donepezil Drug Value Chain
    Figure 61. Donepezil Drug Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String